On August 10, 2023, the company announced that it has issued 12,500,000 Flow-Through Shares at a price of CAD 0.08 per share for the gross proceeds of CAD 1,000,000 in the third and final tranche. In total, an aggregate of 21,250,000 Flow-Through Shares were issued by the Company pursuant to the Offering for proceeds of CAD 1,700,000. The securities are subject to a statutory four month hold period, which expires on December 11, 2023. Completion of the Offering is subject to receipt of final approval of the TSX Venture Exchange. In connection with the Final Tranche, the company paid finder?s fees of CAD 80,000 in cash and issued 1,000,000 non-transferable finder?s warrants to Roche Securities Limited in accordance with TSXV policies. Each Finder?s Warrant entitles the holder thereof to acquire one common share of the Company at a price of CAD 0.08 at any time prior to August 10, 2025.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 4 placees. The company paid Cad 136,000 to the finders and issued 1,700,000 warrants and each warrant entitles the holder to purchase one common share at the price of CAD 0.08 for a period of two years from the date of issuance.